Mechanisms of induction of primary virus‐specific cytotoxic T lymphocyte responses
Marloes L. H. De Bruijn(National Institutes of Health), Cornelis J.M. Melief(ISA Pharmaceuticals (Netherlands)), Ton N. Schumacher(Leiden University Medical Center), W. Martin Kast(University of Southern California), Hidde L. Ploegh(Boston Children's Hospital), John D. Nieland(Aalborg University)
Cited by 49
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity
|Nature Medicine|1995|1.1k
The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.
|The Journal of Immunology|1994|851
Vaccination with cytotoxic T lymphocyte epitope‐containing peptide protects against a tumor induced by human papillomavirus type 16‐transformed cells
|European Journal of Immunology|1993|840
Tumor Exome Analysis Reveals Neoantigen-Specific T-Cell Reactivity in an Ipilimumab-Responsive Melanoma
|Journal of Clinical Oncology|2013|799